More Versus Less Blood Pressure Lowering: An Update.

Area of Science:

• Cardiovascular Medicine
• Clinical Trials
• Hypertension Research

Background:

• Systematic reviews and meta-analyses are crucial for synthesizing evidence on medical interventions.
• Blood pressure (BP) management is a cornerstone of cardiovascular disease prevention.
• Recent large-scale trials have investigated the optimal intensity of BP lowering.

Purpose of the Study:

• To summarize the safety and efficacy of intensive blood pressure lowering.
• To incorporate results from the Systolic Blood Pressure Intervention Trial (SPRINT) into existing meta-analyses.
• To contextualize findings within other major BP-lowering trials like ACCORD and HOPE3.

Main Methods:

• A narrative review incorporating an updated meta-analysis of relevant trials.
• Inclusion of over 20 trials with a total of 54,350 participants.
• Comparison of outcomes between more-intensive versus less-intensive BP lowering strategies.

Main Results:

• More-intensive BP lowering (average 133 mm Hg systolic) compared to less-intensive lowering (average 140 mm Hg systolic) reduced major vascular events.
• Benefits were observed across diverse patient groups, including varying baseline systolic BP, age, and underlying conditions (hypertension, diabetes, renal disease).
• The SPRINT trial results were consistent with previous findings, reinforcing the benefits of intensive BP management.

Conclusions:

• Clear evidence supports the benefits of lowering BP into the 120-140 mm Hg range for high-risk individuals.
• Intensive BP lowering demonstrates a favorable benefit-risk profile for patients at high risk of major vascular events, despite potential side effects.